FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2587964412> ?p ?o ?g. }

• W2587964412 endingPage "65" @default.
• W2587964412 startingPage "52" @default.
• W2587964412 abstract "Objectives: Previous “Treatment of Severe Childhood Aggression” (TOSCA) reports demonstrated that many children with severe physical aggression and attention-deficit/hyperactivity disorder (ADHD) responded well to two randomized treatments (parent training [PT]+stimulant+placebo = Basic vs. PT+stimulant+risperidone = Augmented) for 9 weeks. An important clinical question is whether these favorable outcomes are maintained over longer times. Methods: Clinical responders to the 9-week trial (n = 103/168), defined as Clinical Global Impressions (CGI)-Improvement of much/very much improved plus substantial reduction in parent ratings of disruptiveness, were followed another 12 weeks (21 weeks total) while remaining on blinded treatment. Outcome measures included Clinical Global Impressions scale, Nisonger Child Behavior Rating Form (NCBRF), other parent/teacher-rated scales, laboratory tests, clinician ratings of abnormal movement, and other adverse events (AEs). Results: Parent ratings of problem behavior showed minimal worsening of behavior from end of the 9-week acute trial (expected from regression to the mean after selecting best responders), but outcomes at Extension endpoint were meaningfully improved compared with acute study baseline. As expected, outcomes for Basic and Augmented treatment did not differ among these children selected for good clinical response. During Extension, more Augmented subjects had elevated prolactin; there were no clinically confirmed cases of tardive dyskinesia. Delayed sleep onset was the most frequent Basic AE. We also conducted a last-observation-carried-forward analysis, which included both nonresponders and responders. We found that, at the end of Extension, Augmented subjects had more improvement than Basic subjects on the NCBRF Positive Social subscale (p = 0.005; d = 0.44), the Antisocial Behavior Scale Reactive Aggression subscale (p = 0.03; d = 0.36), and marginally so on the Disruptive Behavior Total subscale (p = 0.058; d = 0.29, the primary outcome). Conclusions: The medium-term outcomes were good for the participants in both treatment groups, perhaps because they were selected for good response. When nonresponders were included in ITT analyses, there was some indication that Augmented surpassed Basic treatment." @default.
• W2587964412 created "2017-02-24" @default.
• W2587964412 creator A5000585575 @default.
• W2587964412 creator A5003135433 @default.
• W2587964412 creator A5032518803 @default.
• W2587964412 creator A5035236451 @default.
• W2587964412 creator A5037364414 @default.
• W2587964412 creator A5038086394 @default.
• W2587964412 creator A5042787535 @default.
• W2587964412 creator A5055854880 @default.
• W2587964412 creator A5057846005 @default.
• W2587964412 creator A5059921483 @default.
• W2587964412 creator A5060340866 @default.
• W2587964412 creator A5069598980 @default.
• W2587964412 creator A5074354902 @default.
• W2587964412 creator A5078168361 @default.
• W2587964412 creator A5081196119 @default.
• W2587964412 creator A5083864774 @default.
• W2587964412 creator A5087993762 @default.
• W2587964412 creator A5088965802 @default.
• W2587964412 date "2017-02-01" @default.
• W2587964412 modified "2023-09-26" @default.
• W2587964412 title "The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders" @default.
• W2587964412 cites W1690841230 @default.
• W2587964412 cites W1922244853 @default.
• W2587964412 cites W1967983347 @default.
• W2587964412 cites W1970465914 @default.
• W2587964412 cites W1974988334 @default.
• W2587964412 cites W1981072297 @default.
• W2587964412 cites W1999689270 @default.
• W2587964412 cites W2014360912 @default.
• W2587964412 cites W2026604013 @default.
• W2587964412 cites W2031947904 @default.
• W2587964412 cites W2069778931 @default.
• W2587964412 cites W2071477423 @default.
• W2587964412 cites W2106249983 @default.
• W2587964412 cites W2135884732 @default.
• W2587964412 cites W2144385879 @default.
• W2587964412 cites W2165379748 @default.
• W2587964412 cites W2167767364 @default.
• W2587964412 cites W2340054991 @default.
• W2587964412 cites W2518157807 @default.
• W2587964412 cites W2601578636 @default.
• W2587964412 cites W4238677474 @default.
• W2587964412 cites W4247130871 @default.
• W2587964412 cites W4248821689 @default.
• W2587964412 doi "https://doi.org/10.1089/cap.2016.0081" @default.
• W2587964412 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5327034" @default.
• W2587964412 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28212067" @default.
• W2587964412 hasPublicationYear "2017" @default.
• W2587964412 type Work @default.
• W2587964412 sameAs 2587964412 @default.
• W2587964412 citedByCount "20" @default.
• W2587964412 countsByYear W25879644122017 @default.
• W2587964412 countsByYear W25879644122018 @default.
• W2587964412 countsByYear W25879644122019 @default.
• W2587964412 countsByYear W25879644122020 @default.
• W2587964412 countsByYear W25879644122021 @default.
• W2587964412 countsByYear W25879644122022 @default.
• W2587964412 countsByYear W25879644122023 @default.
• W2587964412 crossrefType "journal-article" @default.
• W2587964412 hasAuthorship W2587964412A5000585575 @default.
• W2587964412 hasAuthorship W2587964412A5003135433 @default.
• W2587964412 hasAuthorship W2587964412A5032518803 @default.
• W2587964412 hasAuthorship W2587964412A5035236451 @default.
• W2587964412 hasAuthorship W2587964412A5037364414 @default.
• W2587964412 hasAuthorship W2587964412A5038086394 @default.
• W2587964412 hasAuthorship W2587964412A5042787535 @default.
• W2587964412 hasAuthorship W2587964412A5055854880 @default.
• W2587964412 hasAuthorship W2587964412A5057846005 @default.
• W2587964412 hasAuthorship W2587964412A5059921483 @default.
• W2587964412 hasAuthorship W2587964412A5060340866 @default.
• W2587964412 hasAuthorship W2587964412A5069598980 @default.
• W2587964412 hasAuthorship W2587964412A5074354902 @default.
• W2587964412 hasAuthorship W2587964412A5078168361 @default.
• W2587964412 hasAuthorship W2587964412A5081196119 @default.
• W2587964412 hasAuthorship W2587964412A5083864774 @default.
• W2587964412 hasAuthorship W2587964412A5087993762 @default.
• W2587964412 hasAuthorship W2587964412A5088965802 @default.
• W2587964412 hasBestOaLocation W25879644122 @default.
• W2587964412 hasConcept C118552586 @default.
• W2587964412 hasConcept C126322002 @default.
• W2587964412 hasConcept C138496976 @default.
• W2587964412 hasConcept C142724271 @default.
• W2587964412 hasConcept C15744967 @default.
• W2587964412 hasConcept C168563851 @default.
• W2587964412 hasConcept C1862650 @default.
• W2587964412 hasConcept C187212893 @default.
• W2587964412 hasConcept C197934379 @default.
• W2587964412 hasConcept C204787440 @default.
• W2587964412 hasConcept C27081682 @default.
• W2587964412 hasConcept C2776412080 @default.
• W2587964412 hasConcept C2779448149 @default.
• W2587964412 hasConcept C2780057945 @default.
• W2587964412 hasConcept C2780557958 @default.
• W2587964412 hasConcept C535046627 @default.
• W2587964412 hasConcept C71924100 @default.
• W2587964412 hasConcept C83849319 @default.

• next